Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Citric-acid | hsa00030 | Pentose phosphate pathway | 1.77E-04 | 4 | P60891, P51854, P52209, P37837 | PRPS1, TKTL1, PGD, TALDO1 | More | | Citric-acid | hsa00040 | Pentose and glucuronate interconversions | 9.59E-03 | 2 | P15121, P14550 | AKR1B1, AKR1A1 | More | | Citric-acid | hsa00220 | Arginine biosynthesis | 6.71E-05 | 3 | P15104, P05089, P49448 | GLUL, ARG1, GLUD2 | More | | Citric-acid | hsa00230 | Purine metabolism | 1.82E-02 | 1 | P49915 | GMPS | More | | Citric-acid | hsa00250 | Alanine, aspartate and glutamate metabolism | 2.48E-04 | 2 | Q96RQ9, P15104 | IL4I1, GLUL | More | | Citric-acid | hsa00270 | Cysteine and methionine metabolism | 4.90E-02 | 1 | Q96RQ9 | IL4I1 | More | | Citric-acid | hsa00280 | Valine, leucine and isoleucine degradation | 3.29E-02 | 1 | Q96RQ9 | IL4I1 | More | | Citric-acid | hsa00310 | Lysine degradation | 3.15E-02 | 2 | Q96KQ7, P51648 | EHMT2, ALDH3A2 | More | | Citric-acid | hsa00350 | Tyrosine metabolism | 3.29E-02 | 1 | Q96RQ9 | IL4I1 | More | | Citric-acid | hsa00360 | Phenylalanine metabolism | 1.66E-02 | 1 | Q96RQ9 | IL4I1 | More | | Citric-acid | hsa00380 | Tryptophan metabolism | 1.66E-02 | 1 | Q96RQ9 | IL4I1 | More | | Citric-acid | hsa00400 | Phenylalanine, tyrosine and tryptophan biosynthesis | 1.66E-02 | 1 | Q96RQ9 | IL4I1 | More | | Citric-acid | hsa00410 | beta-Alanine metabolism | 3.98E-02 | 1 | Q6ZQY3 | GADL1 | More | | Citric-acid | hsa00440 | Phosphonate and phosphinate metabolism | 4.98E-02 | 1 | Q9Y6K0 | CEPT1 | More | | Citric-acid | hsa00471 | D-Glutamine and D-glutamate metabolism | 9.35E-04 | 2 | Q7Z3D6, P49448 | C14orf159, GLUD2 | More | | Citric-acid | hsa00480 | Glutathione metabolism | 3.29E-04 | 4 | Q9UJ14, Q16772, P09211, P30041 | GGTL3, GSTA3, GSTP1, PRDX6 | More | | Citric-acid | hsa00510 | N-Glycan biosynthesis | 3.15E-02 | 2 | P15907, Q9NR34 | ST6GAL1, MAN1C1 | More | | Citric-acid | hsa00532 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate | 4.70E-02 | 1 | Q9Y2C2 | UST | More | | Citric-acid | hsa00533 | Glycosaminoglycan biosynthesis - keratan sulfate | 2.92E-02 | 1 | Q9NY97 | B3GNT2 | More | | Citric-acid | hsa00561 | Glycerolipid metabolism | 7.94E-03 | 3 | P15121, P14550, Q86XP1 | AKR1B1, AKR1A1, DGKH | More | | Citric-acid | hsa00620 | Pyruvate metabolism | 3.19E-02 | 2 | P40926, P14550 | MDH2, AKR1A1 | More | | Citric-acid | hsa00630 | Glyoxylate and dicarboxylate metabolism | 1.13E-02 | 2 | P40925, P15104 | MDH1, GLUL | More | | Citric-acid | hsa00740 | Riboflavin metabolism | 4.98E-02 | 1 | Q969G6 | RFK | More | | Citric-acid | hsa00750 | Vitamin B6 metabolism | 4.70E-02 | 1 | O00764 | PDXK | More | | Citric-acid | hsa00770 | Pantothenate and CoA biosynthesis | 3.98E-02 | 1 | Q6ZQY3 | GADL1 | More | | Citric-acid | hsa00830 | Retinol metabolism | 3.93E-02 | 3 | P00352, Q9BPW9, O75911 | ALDH1A1, DHRS9, DHRS3 | More | | Citric-acid | hsa00860 | Porphyrin and chlorophyll metabolism | 3.77E-02 | 1 | P53004 | BLVRA | More | | Citric-acid | hsa00910 | Nitrogen metabolism | 1.66E-02 | 1 | P15104 | GLUL | More | | Citric-acid | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 5.46E-03 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | Citric-acid | hsa00982 | Drug metabolism - cytochrome P450 | 1.06E-02 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | Citric-acid | hsa00983 | Drug metabolism - other enzymes | 6.46E-06 | 7 | P49915, P04183, P20839, P32320, P05164, Q16772, P09211 | GMPS, TK1, IMPDH1, CDA, MPO, GSTA3, GSTP1 | More | | Citric-acid | hsa01040 | Biosynthesis of unsaturated fatty acids | 4.77E-02 | 1 | O00767 | SCD | More | | Citric-acid | hsa01100 | Metabolic pathways | 8.43E-03 | 11 | P35790, Q16772, P09211, Q9UJ14, P30041, P40926, Q7KZN9, P15121, Q9UHK6, Q86VZ5, Q9BQB6 | CHKA, GSTA3, GSTP1, GGTL3, PRDX6, MDH2, COX15, AKR1B1, AMACR, SGMS1, VKORC1 | More | | Citric-acid | hsa01210 | 2-Oxocarboxylic acid metabolism | 2.92E-02 | 1 | P50213 | IDH3A | More | | Citric-acid | hsa01230 | Biosynthesis of amino acids | 2.19E-02 | 4 | P51854, P60891, P05089, P37837 | TKTL1, PRPS1, ARG1, TALDO1 | More | | Citric-acid | hsa01240 | Biosynthesis of cofactors | 2.95E-02 | 2 | P13716, P14618 | ALAD, PKM2 | More | | Citric-acid | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 1.80E-02 | 2 | P17252, Q9GZP0 | PRKCA, PDGFD | More | | Citric-acid | hsa01524 | Platinum drug resistance | 4.44E-02 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | Citric-acid | hsa03008 | Ribosome biogenesis in eukaryotes | 4.56E-03 | 3 | Q9NYH9, P78345, Q9BVP2 | UTP6, RPP38, GNL3 | More | | Citric-acid | hsa03010 | Ribosome | 1.60E-02 | 9 | P30050, P40429, P62906, P62917, Q9H0U6, P36578, P05386, P62249, P23396 | RPL12, RPL13A, RPL10A, RPL8, MRPL18, RPL4, RPLP1, RPS16, RPS3 | More | | Citric-acid | hsa03015 | mRNA surveillance pathway | 3.20E-03 | 5 | Q13362, Q14738, O43809, Q15287, Q9UBU9 | PPP2R5C, PPP2R5D, NUDT21, RNPS1, NXF1 | More | | Citric-acid | hsa03030 | DNA replication | 1.48E-02 | 3 | P49005, P33993, P15927 | POLD2, MCM7, RPA2 | More | | Citric-acid | hsa03040 | Spliceosome | 2.10E-04 | 10 | O60508, P08579, P26368, Q13595, Q01130, P84103, Q13243, P11142, Q9Y2W2, O75643 | CDC40, SNRPB2, U2AF2, TRA2A, SFRS2, SFRS3, SFRS5, HSPA8, WBP11, ASCC3L1 | More | | Citric-acid | hsa03050 | Proteasome | 2.42E-02 | 1 | O43242 | PSMD3 | More | | Citric-acid | hsa04010 | MAPK signaling pathway | 5.69E-03 | 4 | P17252, O95267, P09603, Q9GZP0 | PRKCA, RASGRP1, CSF1, PDGFD | More | | Citric-acid | hsa04012 | ErbB signaling pathway | 4.91E-02 | 3 | P49841, Q13191, P42338 | GSK3B, CBLB, PIK3CB | More | | Citric-acid | hsa04014 | Ras signaling pathway | 2.60E-03 | 4 | P09603, Q9GZP0, P17252, O95267 | CSF1, PDGFD, PRKCA, RASGRP1 | More | | Citric-acid | hsa04015 | Rap1 signaling pathway | 1.84E-04 | 5 | P09603, Q9GZP0, P25116, P08514, P17252 | CSF1, PDGFD, F2R, ITGA2B, PRKCA | More | | Citric-acid | hsa04020 | Calcium signaling pathway | 3.18E-05 | 10 | Q96DU7, Q13557, P17252, P21860, P25116, P05141, P12236, P26678, P63092, Q9GZP0 | ITPKC, CAMK2D, PRKCA, ERBB3, F2R, SLC25A5, SLC25A6, PLN, GNAS, PDGFD | More | | Citric-acid | hsa04022 | cGMP-PKG signaling pathway | 9.36E-03 | 6 | P61586, P26678, Q99941, P18848, P05141, P12236 | RHOA, PLN, CREBL1, ATF4, SLC25A5, SLC25A6 | More | | Citric-acid | hsa04060 | Cytokine-cytokine receptor interaction | 7.09E-04 | 14 | P14784, P27930, P14778, P26842, Q06643, Q13651, Q9HBE5, P25024, Q9UBD3, P47992, P01375, P09341, P01730, Q93038 | IL2RB, IL1R2, IL1R1, CD27, LTB, IL10RA, IL21R, CXCR1, XCL2, XCL1, TNF, CXCL1, CD4, TNFRSF25 | More | | Citric-acid | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 9.09E-04 | 7 | P09341, P25024, P47992, Q9UBD3, Q13651, P14784, P01375 | CXCL1, CXCR1, XCL1, XCL2, IL10RA, IL2RB, TNF | More | | Citric-acid | hsa04062 | Chemokine signaling pathway | 6.73E-03 | 9 | P25024, P09341, P47992, Q9UBD3, P07948, P63218, P50151, P43250, Q08881 | CXCR1, CXCL1, XCL1, XCL2, LYN, GNG5, GNG10, GRK6, ITK | More | | Citric-acid | hsa04064 | NF-kappa B signaling pathway | 2.56E-09 | 14 | P10415, O00463, P14778, P01375, Q04759, Q9UDY8, Q13077, Q16548, P07948, P06239, Q13315, P24522, P09341, Q06643 | BCL2, TRAF5, IL1R1, TNF, PRKCQ, MALT1, TRAF1, BCL2A1, LYN, LCK, ATM, GADD45A, CXCL1, LTB | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P42681 | TXK | Tyrosine-protein kinase TXK | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.716 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.744 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.713 | P12724 | RNASE3 | Eosinophil cationic protein | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.871 | P42681 | TXK | Tyrosine-protein kinase TXK | O00463 | TRAF5 | TNF receptor-associated factor 5 | 0.827 | P10153 | RNASE2 | Non-secretory ribonuclease | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.781 | P06239 | LCK | Tyrosine-protein kinase Lck | O00463 | TRAF5 | TNF receptor-associated factor 5 | 0.718 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | O00463 | TRAF5 | TNF receptor-associated factor 5 | 0.945 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | O00463 | TRAF5 | TNF receptor-associated factor 5 | 0.717 | P06239 | LCK | Tyrosine-protein kinase Lck | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.782 | P12724 | RNASE3 | Eosinophil cationic protein | P01375 | TNF | Tumor necrosis factor | 0.774 | P10153 | RNASE2 | Non-secretory ribonuclease | P01375 | TNF | Tumor necrosis factor | 0.735 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01375 | TNF | Tumor necrosis factor | -0.79 | P12724 | RNASE3 | Eosinophil cationic protein | Q04759 | PRKCQ | Protein kinase C theta type | -0.892 | P42681 | TXK | Tyrosine-protein kinase TXK | Q04759 | PRKCQ | Protein kinase C theta type | 0.876 | P10153 | RNASE2 | Non-secretory ribonuclease | Q04759 | PRKCQ | Protein kinase C theta type | -0.801 | P06239 | LCK | Tyrosine-protein kinase Lck | Q04759 | PRKCQ | Protein kinase C theta type | 0.779 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q04759 | PRKCQ | Protein kinase C theta type | 0.803 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.721 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.723 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q13077 | TRAF1 | TNF receptor-associated factor 1 | 0.83 | P12724 | RNASE3 | Eosinophil cationic protein | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.838 | P42681 | TXK | Tyrosine-protein kinase TXK | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.756 | P10153 | RNASE2 | Non-secretory ribonuclease | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.764 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.877 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.701 | P06239 | LCK | Tyrosine-protein kinase Lck | P07948 | LYN | Tyrosine-protein kinase Lyn | -0.701 | P12724 | RNASE3 | Eosinophil cationic protein | P06239 | LCK | Tyrosine-protein kinase Lck | -0.774 | P42681 | TXK | Tyrosine-protein kinase TXK | P06239 | LCK | Tyrosine-protein kinase Lck | 0.734 | P10153 | RNASE2 | Non-secretory ribonuclease | P06239 | LCK | Tyrosine-protein kinase Lck | -0.877 | P06239 | LCK | Tyrosine-protein kinase Lck | P06239 | LCK | Tyrosine-protein kinase Lck | 1 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P06239 | LCK | Tyrosine-protein kinase Lck | 0.774 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q13315 | ATM | Serine-protein kinase ATM | 0.752 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q13315 | ATM | Serine-protein kinase ATM | 0.723 | P42681 | TXK | Tyrosine-protein kinase TXK | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.79 | P06239 | LCK | Tyrosine-protein kinase Lck | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.724 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.75 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.734 | P12724 | RNASE3 | Eosinophil cationic protein | P09341 | CXCL1 | Growth-regulated alpha protein | 0.752 | P42681 | TXK | Tyrosine-protein kinase TXK | P09341 | CXCL1 | Growth-regulated alpha protein | -0.881 | P10153 | RNASE2 | Non-secretory ribonuclease | P09341 | CXCL1 | Growth-regulated alpha protein | 0.701 | P06239 | LCK | Tyrosine-protein kinase Lck | P09341 | CXCL1 | Growth-regulated alpha protein | -0.805 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P09341 | CXCL1 | Growth-regulated alpha protein | -0.802 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09341 | CXCL1 | Growth-regulated alpha protein | -0.789 | P06239 | LCK | Tyrosine-protein kinase Lck | Q06643 | LTB | Lymphotoxin-beta | 0.846 |
| Citric-acid | hsa04071 | Sphingolipid signaling pathway | 1.19E-02 | 5 | P21453, Q9H228, Q13362, Q9BX95, P10415 | S1PR1, EDG8, PPP2R5C, SGPP1, BCL2 | More | | Citric-acid | hsa04072 | Phospholipase D signaling pathway | 7.75E-03 | 3 | P25116, P17252, Q9GZP0 | F2R, PRKCA, PDGFD | More | | Citric-acid | hsa04080 | Neuroactive ligand-receptor interaction | 1.00E-02 | 7 | P08311, Q15722, P21453, Q9H228, O00398, P21730, P07550 | CTSG, LTB4R, S1PR1, EDG8, P2RY10, C5AR1, ADRB2 | More | | Citric-acid | hsa04114 | Oocyte meiosis | 1.06E-02 | 5 | Q15418, P0DP23, Q08828, Q13362, Q14738 | RPS6KA1, CALM1, ADCY1, PPP2R5C, PPP2R5D | More | | Citric-acid | hsa04137 | Mitophagy - animal | 2.06E-02 | 3 | P67870, P19532, P18848 | CSNK2B, TFE3, ATF4 | More | | Citric-acid | hsa04140 | Autophagy - animal | 4.72E-04 | 5 | P22694, Q14643, P10415, Q9H1Y0, Q04759 | PRKACB, ITPR1, BCL2, ATG5, PRKCQ | More | | Citric-acid | hsa04141 | Protein processing in endoplasmic reticulum | 3.03E-02 | 4 | Q12933, P49257, P54727, Q99933 | TRAF2, LMAN1, RAD23B, BAG1 | More | | Citric-acid | hsa04144 | Endocytosis | 2.81E-02 | 6 | Q13191, P11142, P25024, P43250, P14784, Q9Y5X3 | CBLB, HSPA8, CXCR1, GRK6, IL2RB, SNX5 | More | | Citric-acid | hsa04145 | Phagosome | 4.71E-03 | 7 | O75015, Q15080, P05164, P78380, O60603, P35443, P13765 | FCGR3B, NCF4, MPO, OLR1, TLR2, THBS4, HLA-DOB | More | | Citric-acid | hsa04150 | mTOR signaling pathway | 6.20E-03 | 2 | Q9NQL2, Q13322 | RRAGD, GRB10 | More | | Citric-acid | hsa04151 | PI3K-Akt signaling pathway | 3.68E-04 | 14 | P21860, P25116, P27348, P09603, O14944, Q9GZP0, P07900, Q15831, P08514, P22105, Q99941, P18848, P17252, O95988 | ERBB3, F2R, YWHAQ, CSF1, EREG, PDGFD, HSP90AA1, STK11, ITGA2B, TNXB, CREBL1, ATF4, PRKCA, TCL1B | More | | Citric-acid | hsa04210 | Apoptosis | 3.44E-02 | 7 | Q13315, P10415, O76075, P24522, Q16548, P43234, Q14643 | ATM, BCL2, DFFB, GADD45A, BCL2A1, CTSO, ITPR1 | More | | Citric-acid | hsa04217 | Necroptosis | 4.39E-02 | 2 | Q12933, P15104 | TRAF2, GLUL | More | | Citric-acid | hsa04260 | Cardiac muscle contraction | 3.17E-02 | 2 | P09493, P14927 | TPM1, UQCRB | More | | Citric-acid | hsa04261 | Adrenergic signaling in cardiomyocytes | 1.23E-03 | 9 | P63092, Q08828, Q99941, P18848, P26678, Q13362, Q14738, P0DP23, Q13557 | GNAS, ADCY1, CREBL1, ATF4, PLN, PPP2R5C, PPP2R5D, CALM1, CAMK2D | More | | Citric-acid | hsa04340 | Hedgehog signaling pathway | 2.66E-03 | 3 | P22694, Q13635, P10415 | PRKACB, PTCH1, BCL2 | More | | Citric-acid | hsa04350 | TGF-beta signaling pathway | 3.68E-02 | 2 | Q14766, Q15583 | LTBP1, TGIF1 | More | | Citric-acid | hsa04360 | Axon guidance | 9.54E-03 | 3 | P20827, P23528, Q06124 | EFNA1, CFL1, PTPN11 | More | | Citric-acid | hsa04390 | Hippo signaling pathway | 4.79E-02 | 3 | P63261, P04628, O43623 | ACTG1, WNT1, SNAI2 | More | | Citric-acid | hsa04392 | Hippo signaling pathway - multiple species | 6.35E-03 | 1 | Q9UGP4 | LIMD1 | More | | Citric-acid | hsa04510 | Focal adhesion | 3.52E-03 | 6 | P08514, Q15942, P17252, P51636, P30281, Q9GZP0 | ITGA2B, ZYX, PRKCA, CAV2, CCND3, PDGFD | More | | Citric-acid | hsa04512 | ECM-receptor interaction | 1.90E-02 | 2 | P26012, P16070 | ITGB8, CD44 | More | | Citric-acid | hsa04540 | Gap junction | 2.22E-02 | 2 | P17252, Q9GZP0 | PRKCA, PDGFD | More | | Citric-acid | hsa04610 | Complement and coagulation cascades | 4.59E-03 | 3 | P25116, P0C0L4, Q9Y279 | F2R, C4A, VSIG4 | More | | Citric-acid | hsa04611 | Platelet activation | 4.53E-03 | 3 | P25116, O95267, P08514 | F2R, RASGRP1, ITGA2B | More | | Citric-acid | hsa04612 | Antigen processing and presentation | 3.32E-07 | 8 | P13765, P48382, P01730, P26715, P26717, Q13241, P01732, P01375 | HLA-DOB, RFX5, CD4, KLRC1, KLRC2, KLRD1, CD8A, TNF | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P12724 | RNASE3 | Eosinophil cationic protein | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.856 | P10153 | RNASE2 | Non-secretory ribonuclease | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.724 | P06239 | LCK | Tyrosine-protein kinase Lck | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.777 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.85 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.795 | P12724 | RNASE3 | Eosinophil cationic protein | P48382 | RFX5 | DNA-binding protein RFX5 | -0.84 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P48382 | RFX5 | DNA-binding protein RFX5 | 0.826 | P06239 | LCK | Tyrosine-protein kinase Lck | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.746 | P12724 | RNASE3 | Eosinophil cationic protein | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.807 | P10153 | RNASE2 | Non-secretory ribonuclease | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.735 | P06239 | LCK | Tyrosine-protein kinase Lck | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.756 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.943 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.853 | P12724 | RNASE3 | Eosinophil cationic protein | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.807 | P10153 | RNASE2 | Non-secretory ribonuclease | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.735 | P06239 | LCK | Tyrosine-protein kinase Lck | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.756 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.943 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.853 | P12724 | RNASE3 | Eosinophil cationic protein | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.723 | P06239 | LCK | Tyrosine-protein kinase Lck | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.758 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.852 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.863 | P12724 | RNASE3 | Eosinophil cationic protein | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.763 | P10153 | RNASE2 | Non-secretory ribonuclease | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.712 | P06239 | LCK | Tyrosine-protein kinase Lck | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.841 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.803 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.92 | P12724 | RNASE3 | Eosinophil cationic protein | P01375 | TNF | Tumor necrosis factor | 0.774 | P10153 | RNASE2 | Non-secretory ribonuclease | P01375 | TNF | Tumor necrosis factor | 0.735 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01375 | TNF | Tumor necrosis factor | -0.79 |
| Citric-acid | hsa04613 | Neutrophil extracellular trap formation | 4.93E-02 | 8 | O60603, P05164, P08246, Q9UM07, Q15080, P20160, P08311, P21730 | TLR2, MPO, ELA2, PADI4, NCF4, AZU1, CTSG, C5AR1 | More | | Citric-acid | hsa04621 | NOD-like receptor signaling pathway | 9.20E-03 | 8 | Q14643, P10599, P43490, O00463, P29728, P01375, P09341, P12838 | ITPR1, TXN, PBEF1, TRAF5, OAS2, TNF, CXCL1, DEFA4 | More | | Citric-acid | hsa04622 | RIG-I-like receptor signaling pathway | 4.90E-02 | 1 | Q12933 | TRAF2 | More | | Citric-acid | hsa04640 | Hematopoietic cell lineage | 2.44E-08 | 15 | P13612, P08514, P14778, P27930, P15144, P11836, P25063, P07766, P09693, P01732, P01730, P09564, P13765, P01375, P09603 | ITGA4, ITGA2B, IL1R1, IL1R2, ANPEP, MS4A1, CD24, CD3E, CD3G, CD8A, CD4, CD7, HLA-DOB, TNF, CSF1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P06239 | LCK | Tyrosine-protein kinase Lck | P13612 | ITGA4 | Integrin alpha-4 | 0.732 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P13612 | ITGA4 | Integrin alpha-4 | 0.774 | P07998 | RNASE1 | Ribonuclease pancreatic | P08514 | ITGA2B | Integrin alpha-IIb | 0.734 | P06239 | LCK | Tyrosine-protein kinase Lck | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.782 | P12724 | RNASE3 | Eosinophil cationic protein | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.714 | P10153 | RNASE2 | Non-secretory ribonuclease | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.749 | P06239 | LCK | Tyrosine-protein kinase Lck | P27930 | IL1R2 | Interleukin-1 receptor type 2 | -0.779 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P27930 | IL1R2 | Interleukin-1 receptor type 2 | -0.727 | P12724 | RNASE3 | Eosinophil cationic protein | P15144 | ANPEP | Aminopeptidase N | 0.736 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P15144 | ANPEP | Aminopeptidase N | -0.757 | P07998 | RNASE1 | Ribonuclease pancreatic | P11836 | MS4A1 | B-lymphocyte antigen CD20 | 0.716 | P12724 | RNASE3 | Eosinophil cationic protein | P25063 | CD24 | Signal transducer CD24 | 0.858 | P10153 | RNASE2 | Non-secretory ribonuclease | P25063 | CD24 | Signal transducer CD24 | 0.822 | P06239 | LCK | Tyrosine-protein kinase Lck | P25063 | CD24 | Signal transducer CD24 | -0.779 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P25063 | CD24 | Signal transducer CD24 | -0.839 | P10153 | RNASE2 | Non-secretory ribonuclease | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.795 | P06239 | LCK | Tyrosine-protein kinase Lck | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.928 | P06239 | LCK | Tyrosine-protein kinase Lck | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.752 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.813 | P12724 | RNASE3 | Eosinophil cationic protein | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.763 | P10153 | RNASE2 | Non-secretory ribonuclease | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.712 | P06239 | LCK | Tyrosine-protein kinase Lck | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.841 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.803 | P06239 | LCK | Tyrosine-protein kinase Lck | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.746 | P10153 | RNASE2 | Non-secretory ribonuclease | P09564 | CD7 | T-cell antigen CD7 | -0.712 | P06239 | LCK | Tyrosine-protein kinase Lck | P09564 | CD7 | T-cell antigen CD7 | 0.84 | P12724 | RNASE3 | Eosinophil cationic protein | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.856 | P10153 | RNASE2 | Non-secretory ribonuclease | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.724 | P06239 | LCK | Tyrosine-protein kinase Lck | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.777 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.85 | P12724 | RNASE3 | Eosinophil cationic protein | P01375 | TNF | Tumor necrosis factor | 0.774 | P10153 | RNASE2 | Non-secretory ribonuclease | P01375 | TNF | Tumor necrosis factor | 0.735 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01375 | TNF | Tumor necrosis factor | -0.79 | P07998 | RNASE1 | Ribonuclease pancreatic | P09603 | CSF1 | Macrophage colony-stimulating factor 1 | -0.784 |
| Citric-acid | hsa04650 | Natural killer cell mediated cytotoxicity | 2.86E-12 | 12 | P01375, P17252, P06239, O60880, P20963, P42338, Q13241, P26718, O14931, O75015, P26717, P26715 | TNF, PRKCA, LCK, SH2D1A, CD247, PIK3CB, KLRD1, KLRK1, NCR3, FCGR3B, KLRC2, KLRC1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P12724 | RNASE3 | Eosinophil cationic protein | P01375 | TNF | Tumor necrosis factor | 0.774 | P10153 | RNASE2 | Non-secretory ribonuclease | P01375 | TNF | Tumor necrosis factor | 0.735 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01375 | TNF | Tumor necrosis factor | -0.79 | P07998 | RNASE1 | Ribonuclease pancreatic | P17252 | PRKCA | Protein kinase C alpha type | 0.703 | P12724 | RNASE3 | Eosinophil cationic protein | P06239 | LCK | Tyrosine-protein kinase Lck | -0.774 | P42681 | TXK | Tyrosine-protein kinase TXK | P06239 | LCK | Tyrosine-protein kinase Lck | 0.734 | P10153 | RNASE2 | Non-secretory ribonuclease | P06239 | LCK | Tyrosine-protein kinase Lck | -0.877 | P06239 | LCK | Tyrosine-protein kinase Lck | P06239 | LCK | Tyrosine-protein kinase Lck | 1 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P06239 | LCK | Tyrosine-protein kinase Lck | 0.774 | P12724 | RNASE3 | Eosinophil cationic protein | O60880 | SH2D1A | SH2 domain-containing protein 1A | -0.883 | P42681 | TXK | Tyrosine-protein kinase TXK | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.881 | P10153 | RNASE2 | Non-secretory ribonuclease | O60880 | SH2D1A | SH2 domain-containing protein 1A | -0.873 | P06239 | LCK | Tyrosine-protein kinase Lck | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.906 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.862 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.869 | P12724 | RNASE3 | Eosinophil cationic protein | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.855 | P42681 | TXK | Tyrosine-protein kinase TXK | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.811 | P10153 | RNASE2 | Non-secretory ribonuclease | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.893 | P06239 | LCK | Tyrosine-protein kinase Lck | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.927 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.839 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | P10153 | RNASE2 | Non-secretory ribonuclease | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.75 | P12724 | RNASE3 | Eosinophil cationic protein | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.723 | P42681 | TXK | Tyrosine-protein kinase TXK | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.888 | P06239 | LCK | Tyrosine-protein kinase Lck | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.758 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.852 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.863 | P12724 | RNASE3 | Eosinophil cationic protein | P26718 | KLRK1 | NKG2-D type II integral membrane protein | -0.872 | P42681 | TXK | Tyrosine-protein kinase TXK | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.869 | P10153 | RNASE2 | Non-secretory ribonuclease | P26718 | KLRK1 | NKG2-D type II integral membrane protein | -0.856 | P06239 | LCK | Tyrosine-protein kinase Lck | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.886 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.922 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.762 | P06239 | LCK | Tyrosine-protein kinase Lck | O14931 | NCR3 | Natural cytotoxicity triggering receptor 3 | 0.732 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | -0.778 | P07998 | RNASE1 | Ribonuclease pancreatic | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.716 | P12724 | RNASE3 | Eosinophil cationic protein | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.807 | P42681 | TXK | Tyrosine-protein kinase TXK | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.901 | P10153 | RNASE2 | Non-secretory ribonuclease | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.735 | P06239 | LCK | Tyrosine-protein kinase Lck | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.756 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.943 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.853 | P07998 | RNASE1 | Ribonuclease pancreatic | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.716 | P12724 | RNASE3 | Eosinophil cationic protein | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.807 | P42681 | TXK | Tyrosine-protein kinase TXK | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.901 | P10153 | RNASE2 | Non-secretory ribonuclease | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.735 | P06239 | LCK | Tyrosine-protein kinase Lck | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.756 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.943 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.853 |
| Citric-acid | hsa04657 | IL-17 signaling pathway | 2.58E-02 | 5 | O00463, P09341, P14780, P80188, P01375 | TRAF5, CXCL1, MMP9, LCN2, TNF | More | | Citric-acid | hsa04658 | Th1 and Th2 cell differentiation | 3.85E-21 | 12 | Q04759, P07766, P20963, P09693, P01730, P06239, Q14765, P23771, Q9UL17, P14784, P13765, Q13761 | PRKCQ, CD3E, CD247, CD3G, CD4, LCK, STAT4, GATA3, TBX21, IL2RB, HLA-DOB, RUNX3 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P12724 | RNASE3 | Eosinophil cationic protein | Q04759 | PRKCQ | Protein kinase C theta type | -0.892 | P42681 | TXK | Tyrosine-protein kinase TXK | Q04759 | PRKCQ | Protein kinase C theta type | 0.876 | P10153 | RNASE2 | Non-secretory ribonuclease | Q04759 | PRKCQ | Protein kinase C theta type | -0.801 | P06239 | LCK | Tyrosine-protein kinase Lck | Q04759 | PRKCQ | Protein kinase C theta type | 0.779 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q04759 | PRKCQ | Protein kinase C theta type | 0.803 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | P10153 | RNASE2 | Non-secretory ribonuclease | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.795 | P07948 | LYN | Tyrosine-protein kinase Lyn | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.824 | P06239 | LCK | Tyrosine-protein kinase Lck | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.928 | P12724 | RNASE3 | Eosinophil cationic protein | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.855 | P42681 | TXK | Tyrosine-protein kinase TXK | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.811 | P10153 | RNASE2 | Non-secretory ribonuclease | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.893 | P06239 | LCK | Tyrosine-protein kinase Lck | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.927 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.839 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | P42681 | TXK | Tyrosine-protein kinase TXK | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.838 | P06239 | LCK | Tyrosine-protein kinase Lck | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.752 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.813 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | P06239 | LCK | Tyrosine-protein kinase Lck | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.746 | P12724 | RNASE3 | Eosinophil cationic protein | P06239 | LCK | Tyrosine-protein kinase Lck | -0.774 | P42681 | TXK | Tyrosine-protein kinase TXK | P06239 | LCK | Tyrosine-protein kinase Lck | 0.734 | P10153 | RNASE2 | Non-secretory ribonuclease | P06239 | LCK | Tyrosine-protein kinase Lck | -0.877 | P07948 | LYN | Tyrosine-protein kinase Lyn | P06239 | LCK | Tyrosine-protein kinase Lck | -0.701 | P06239 | LCK | Tyrosine-protein kinase Lck | P06239 | LCK | Tyrosine-protein kinase Lck | 1 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P06239 | LCK | Tyrosine-protein kinase Lck | 0.774 | P12724 | RNASE3 | Eosinophil cationic protein | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.835 | P42681 | TXK | Tyrosine-protein kinase TXK | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.771 | P10153 | RNASE2 | Non-secretory ribonuclease | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.772 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.904 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.742 | P12724 | RNASE3 | Eosinophil cationic protein | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.71 | P42681 | TXK | Tyrosine-protein kinase TXK | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.856 | P06239 | LCK | Tyrosine-protein kinase Lck | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.77 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.784 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.85 | P12724 | RNASE3 | Eosinophil cationic protein | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.805 | P42681 | TXK | Tyrosine-protein kinase TXK | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.849 | P10153 | RNASE2 | Non-secretory ribonuclease | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.852 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.719 | P06239 | LCK | Tyrosine-protein kinase Lck | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.866 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.884 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.735 | P10153 | RNASE2 | Non-secretory ribonuclease | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.703 | P07948 | LYN | Tyrosine-protein kinase Lyn | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.771 | P06239 | LCK | Tyrosine-protein kinase Lck | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.727 | P12724 | RNASE3 | Eosinophil cationic protein | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.856 | P42681 | TXK | Tyrosine-protein kinase TXK | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.89 | P10153 | RNASE2 | Non-secretory ribonuclease | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.724 | P06239 | LCK | Tyrosine-protein kinase Lck | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.777 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.85 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.795 | P10153 | RNASE2 | Non-secretory ribonuclease | Q13761 | RUNX3 | Runt-related transcription factor 3 | -0.755 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q13761 | RUNX3 | Runt-related transcription factor 3 | -0.855 | P06239 | LCK | Tyrosine-protein kinase Lck | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.85 |
| Citric-acid | hsa04659 | Th17 cell differentiation | 2.26E-15 | 14 | Q04759, P01730, P06239, P14784, P13765, P14778, Q9HBE5, Q9UL17, P23771, Q13485, P08238, P07766, P09693, P20963 | PRKCQ, CD4, LCK, IL2RB, HLA-DOB, IL1R1, IL21R, TBX21, GATA3, SMAD4, HSP90AB1, CD3E, CD3G, CD247 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P12724 | RNASE3 | Eosinophil cationic protein | Q04759 | PRKCQ | Protein kinase C theta type | -0.892 | P42681 | TXK | Tyrosine-protein kinase TXK | Q04759 | PRKCQ | Protein kinase C theta type | 0.876 | P10153 | RNASE2 | Non-secretory ribonuclease | Q04759 | PRKCQ | Protein kinase C theta type | -0.801 | P06239 | LCK | Tyrosine-protein kinase Lck | Q04759 | PRKCQ | Protein kinase C theta type | 0.779 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q04759 | PRKCQ | Protein kinase C theta type | 0.803 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | P06239 | LCK | Tyrosine-protein kinase Lck | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.746 | P12724 | RNASE3 | Eosinophil cationic protein | P06239 | LCK | Tyrosine-protein kinase Lck | -0.774 | P42681 | TXK | Tyrosine-protein kinase TXK | P06239 | LCK | Tyrosine-protein kinase Lck | 0.734 | P10153 | RNASE2 | Non-secretory ribonuclease | P06239 | LCK | Tyrosine-protein kinase Lck | -0.877 | P07948 | LYN | Tyrosine-protein kinase Lyn | P06239 | LCK | Tyrosine-protein kinase Lck | -0.701 | P06239 | LCK | Tyrosine-protein kinase Lck | P06239 | LCK | Tyrosine-protein kinase Lck | 1 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P06239 | LCK | Tyrosine-protein kinase Lck | 0.774 | P10153 | RNASE2 | Non-secretory ribonuclease | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.703 | P07948 | LYN | Tyrosine-protein kinase Lyn | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.771 | P06239 | LCK | Tyrosine-protein kinase Lck | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.727 | P12724 | RNASE3 | Eosinophil cationic protein | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.856 | P42681 | TXK | Tyrosine-protein kinase TXK | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.89 | P10153 | RNASE2 | Non-secretory ribonuclease | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.724 | P06239 | LCK | Tyrosine-protein kinase Lck | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.777 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.85 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.795 | P07948 | LYN | Tyrosine-protein kinase Lyn | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.714 | P06239 | LCK | Tyrosine-protein kinase Lck | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.782 | P12724 | RNASE3 | Eosinophil cationic protein | Q9HBE5 | IL21R | Interleukin-21 receptor | -0.839 | P10153 | RNASE2 | Non-secretory ribonuclease | Q9HBE5 | IL21R | Interleukin-21 receptor | -0.777 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q9HBE5 | IL21R | Interleukin-21 receptor | 0.713 | P12724 | RNASE3 | Eosinophil cationic protein | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.805 | P42681 | TXK | Tyrosine-protein kinase TXK | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.849 | P10153 | RNASE2 | Non-secretory ribonuclease | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.852 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.719 | P06239 | LCK | Tyrosine-protein kinase Lck | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.866 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.884 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.735 | P12724 | RNASE3 | Eosinophil cationic protein | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.71 | P42681 | TXK | Tyrosine-protein kinase TXK | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.856 | P06239 | LCK | Tyrosine-protein kinase Lck | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.77 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.784 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.85 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.729 | P07948 | LYN | Tyrosine-protein kinase Lyn | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.782 | P10153 | RNASE2 | Non-secretory ribonuclease | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.795 | P07948 | LYN | Tyrosine-protein kinase Lyn | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.824 | P06239 | LCK | Tyrosine-protein kinase Lck | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.928 | P42681 | TXK | Tyrosine-protein kinase TXK | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.838 | P06239 | LCK | Tyrosine-protein kinase Lck | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.752 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.813 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | P12724 | RNASE3 | Eosinophil cationic protein | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.855 | P42681 | TXK | Tyrosine-protein kinase TXK | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.811 | P10153 | RNASE2 | Non-secretory ribonuclease | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.893 | P06239 | LCK | Tyrosine-protein kinase Lck | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.927 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.839 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 |
| Citric-acid | hsa04660 | T cell receptor signaling pathway | 1.29E-13 | 15 | P01375, Q9UDY8, Q04759, P42338, P10747, O95267, Q08881, P07766, P20963, P09693, P01730, P01732, Q13191, P06239, P49841 | TNF, MALT1, PRKCQ, PIK3CB, CD28, RASGRP1, ITK, CD3E, CD247, CD3G, CD4, CD8A, CBLB, LCK, GSK3B | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P12724 | RNASE3 | Eosinophil cationic protein | P01375 | TNF | Tumor necrosis factor | 0.774 | P10153 | RNASE2 | Non-secretory ribonuclease | P01375 | TNF | Tumor necrosis factor | 0.735 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01375 | TNF | Tumor necrosis factor | -0.79 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.721 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.723 | P12724 | RNASE3 | Eosinophil cationic protein | Q04759 | PRKCQ | Protein kinase C theta type | -0.892 | P42681 | TXK | Tyrosine-protein kinase TXK | Q04759 | PRKCQ | Protein kinase C theta type | 0.876 | P10153 | RNASE2 | Non-secretory ribonuclease | Q04759 | PRKCQ | Protein kinase C theta type | -0.801 | P06239 | LCK | Tyrosine-protein kinase Lck | Q04759 | PRKCQ | Protein kinase C theta type | 0.779 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q04759 | PRKCQ | Protein kinase C theta type | 0.803 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | P10153 | RNASE2 | Non-secretory ribonuclease | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.75 | P42681 | TXK | Tyrosine-protein kinase TXK | P10747 | CD28 | T-cell-specific surface glycoprotein CD28 | 0.776 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P10747 | CD28 | T-cell-specific surface glycoprotein CD28 | 0.794 | P42681 | TXK | Tyrosine-protein kinase TXK | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | 0.857 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | 0.925 | P12724 | RNASE3 | Eosinophil cationic protein | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.856 | P42681 | TXK | Tyrosine-protein kinase TXK | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 0.847 | P10153 | RNASE2 | Non-secretory ribonuclease | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.783 | P06239 | LCK | Tyrosine-protein kinase Lck | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 0.774 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 1 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 0.746 | P10153 | RNASE2 | Non-secretory ribonuclease | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.795 | P06239 | LCK | Tyrosine-protein kinase Lck | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.928 | P12724 | RNASE3 | Eosinophil cationic protein | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.855 | P42681 | TXK | Tyrosine-protein kinase TXK | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.811 | P10153 | RNASE2 | Non-secretory ribonuclease | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.893 | P06239 | LCK | Tyrosine-protein kinase Lck | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.927 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.839 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | P42681 | TXK | Tyrosine-protein kinase TXK | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.838 | P06239 | LCK | Tyrosine-protein kinase Lck | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.752 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.813 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | P06239 | LCK | Tyrosine-protein kinase Lck | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.746 | P12724 | RNASE3 | Eosinophil cationic protein | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.763 | P42681 | TXK | Tyrosine-protein kinase TXK | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.9 | P10153 | RNASE2 | Non-secretory ribonuclease | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.712 | P06239 | LCK | Tyrosine-protein kinase Lck | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.841 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.803 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.92 | P42681 | TXK | Tyrosine-protein kinase TXK | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.716 | P10153 | RNASE2 | Non-secretory ribonuclease | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | -0.703 | P06239 | LCK | Tyrosine-protein kinase Lck | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.714 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.811 | P12724 | RNASE3 | Eosinophil cationic protein | P06239 | LCK | Tyrosine-protein kinase Lck | -0.774 | P42681 | TXK | Tyrosine-protein kinase TXK | P06239 | LCK | Tyrosine-protein kinase Lck | 0.734 | P10153 | RNASE2 | Non-secretory ribonuclease | P06239 | LCK | Tyrosine-protein kinase Lck | -0.877 | P06239 | LCK | Tyrosine-protein kinase Lck | P06239 | LCK | Tyrosine-protein kinase Lck | 1 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P06239 | LCK | Tyrosine-protein kinase Lck | 0.774 | P10153 | RNASE2 | Non-secretory ribonuclease | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.721 |
| Citric-acid | hsa04662 | B cell receptor signaling pathway | 4.07E-02 | 4 | P42338, P60033, P07948, Q8N149 | PIK3CB, CD81, LYN, LILRA2 | More | | Citric-acid | hsa04668 | TNF signaling pathway | 3.38E-03 | 6 | P01375, O00463, P09341, P20749, P14780, P42338 | TNF, TRAF5, CXCL1, BCL3, MMP9, PIK3CB | More | | Citric-acid | hsa04714 | Thermogenesis | 4.22E-04 | 9 | P15336, Q08828, Q6STE5, Q969G3, P63261, Q15418, P13073, P12074, O95298 | ATF2, ADCY1, SMARCD3, SMARCE1, ACTG1, RPS6KA1, COX4I1, COX6A1, NDUFC2 | More | | Citric-acid | hsa04720 | Long-term potentiation | 5.46E-03 | 4 | P0DP23, Q15418, P18848, Q08828 | CALM1, RPS6KA1, ATF4, ADCY1 | More | | Citric-acid | hsa04724 | Glutamatergic synapse | 2.22E-02 | 4 | O15399, P63218, P50151, P15104 | GRIN2D, GNG5, GNG10, GLUL | More | | Citric-acid | hsa04727 | GABAergic synapse | 4.42E-02 | 3 | P63218, P50151, P15104 | GNG5, GNG10, GLUL | More | | Citric-acid | hsa04728 | Dopaminergic synapse | 3.29E-02 | 4 | P18848, Q13362, Q14738, P0DP23 | ATF4, PPP2R5C, PPP2R5D, CALM1 | More | | Citric-acid | hsa04750 | Inflammatory mediator regulation of TRP channels | 1.70E-03 | 5 | P22694, P42338, Q14643, P24723, Q04759 | PRKACB, PIK3CB, ITPR1, PRKCH, PRKCQ | More | | Citric-acid | hsa04810 | Regulation of actin cytoskeleton | 1.21E-02 | 3 | P08514, Q9GZP0, P25116 | ITGA2B, PDGFD, F2R | More | | Citric-acid | hsa04910 | Insulin signaling pathway | 1.08E-02 | 5 | P22694, P06737, P42338, P49841, Q13191 | PRKACB, PYGL, PIK3CB, GSK3B, CBLB | More | | Citric-acid | hsa04911 | Insulin secretion | 4.47E-03 | 4 | P63092, Q99941, P18848, Q13557 | GNAS, CREBL1, ATF4, CAMK2D | More | | Citric-acid | hsa04912 | GnRH signaling pathway | 4.99E-02 | 1 | P18146 | EGR1 | More | | Citric-acid | hsa04920 | Adipocytokine signaling pathway | 2.06E-02 | 2 | Q06124, Q9Y478 | PTPN11, PRKAB1 | More | | Citric-acid | hsa04922 | Glucagon signaling pathway | 7.57E-03 | 5 | P14618, P22694, P06737, Q12778, Q14643 | PKM2, PRKACB, PYGL, FOXO1, ITPR1 | More | | Citric-acid | hsa04924 | Renin secretion | 1.04E-02 | 3 | P22694, P07550, Q14643 | PRKACB, ADRB2, ITPR1 | More | | Citric-acid | hsa04925 | Aldosterone synthesis and secretion | 1.68E-02 | 4 | Q99941, P18848, P63092, Q13557 | CREBL1, ATF4, GNAS, CAMK2D | More | | Citric-acid | hsa04927 | Cortisol synthesis and secretion | 2.40E-02 | 3 | Q99941, P18848, P63092 | CREBL1, ATF4, GNAS | More | | Citric-acid | hsa04928 | Parathyroid hormone synthesis, secretion and action | 2.59E-03 | 8 | Q14643, P63092, P22694, P23771, P61586, Q99941, P18848, P10415 | ITPR1, GNAS, PRKACB, GATA3, RHOA, CREBL1, ATF4, BCL2 | More | | Citric-acid | hsa04931 | Insulin resistance | 7.80E-03 | 5 | P01375, P42338, P49841, Q04759, P06737 | TNF, PIK3CB, GSK3B, PRKCQ, PYGL | More | | Citric-acid | hsa04932 | Non-alcoholic fatty liver disease | 4.04E-02 | 4 | P18848, P13073, P12074, O95298 | ATF4, COX4I1, COX6A1, NDUFC2 | More | | Citric-acid | hsa04934 | Cushing syndrome | 6.95E-05 | 7 | Q99941, P18848, P63092, O15169, Q13557, P46527, O00170 | CREBL1, ATF4, GNAS, AXIN1, CAMK2D, CDKN1B, AIP | More | | Citric-acid | hsa05010 | Alzheimer disease | 1.68E-04 | 16 | Q92542, O15239, O95298, P05496, P13073, P12074, Q00535, P0DP23, P18848, O15169, P67870, P05141, P12236, P28070, P43686, P62195 | NCSTN, NDUFA1, NDUFC2, ATP5G1, COX4I1, COX6A1, CDK5, CALM1, ATF4, AXIN1, CSNK2B, SLC25A5, SLC25A6, PSMB4, PSMC4, PSMC5 | More | | Citric-acid | hsa05012 | Parkinson disease | 1.15E-04 | 14 | O15239, O95298, P13073, P12074, P05496, P05141, P12236, P63092, P18848, P28070, P43686, P62195, P0DP23, Q13557 | NDUFA1, NDUFC2, COX4I1, COX6A1, ATP5G1, SLC25A5, SLC25A6, GNAS, ATF4, PSMB4, PSMC4, PSMC5, CALM1, CAMK2D | More | | Citric-acid | hsa05014 | Amyotrophic lateral sclerosis | 4.41E-03 | 14 | P20333, O15239, O95298, P13073, P12074, P05496, P18848, P28070, P43686, P62195, Q8TEV9, P51991, P35658, Q9UBU9 | TNFRSF1B, NDUFA1, NDUFC2, COX4I1, COX6A1, ATP5G1, ATF4, PSMB4, PSMC4, PSMC5, SMCR8, HNRPA3, NUP214, NXF1 | More | | Citric-acid | hsa05016 | Huntington disease | 1.67E-02 | 7 | O95298, P13073, P12074, P24928, P62487, P05141, P28070 | NDUFC2, COX4I1, COX6A1, POLR2A, POLR2G, SLC25A5, PSMB4 | More | | Citric-acid | hsa05017 | Spinocerebellar ataxia | 1.89E-02 | 5 | Q92915, O15399, P42338, O43242, P21796 | FGF14, GRIN2D, PIK3CB, PSMD3, VDAC1 | More | | Citric-acid | hsa05020 | Prion disease | 1.21E-03 | 14 | P46531, O15239, O95298, P05496, P13073, P12074, P18848, P05141, P12236, P28070, P43686, P62195, P67870, Q99941 | NOTCH1, NDUFA1, NDUFC2, ATP5G1, COX4I1, COX6A1, ATF4, SLC25A5, SLC25A6, PSMB4, PSMC4, PSMC5, CSNK2B, CREBL1 | More | | Citric-acid | hsa05022 | Pathways of neurodegeneration - multiple diseases | 2.06E-04 | 18 | P67870, O15239, O95298, P13073, P12074, P05496, Q8TEV9, P18848, P05141, P12236, P20333, Q00535, O15169, P0DP23, Q13557, P28070, P43686, P62195 | CSNK2B, NDUFA1, NDUFC2, COX4I1, COX6A1, ATP5G1, SMCR8, ATF4, SLC25A5, SLC25A6, TNFRSF1B, CDK5, AXIN1, CALM1, CAMK2D, PSMB4, PSMC4, PSMC5 | More | | Citric-acid | hsa05030 | Cocaine addiction | 2.40E-02 | 3 | P63092, Q99941, P18848 | GNAS, CREBL1, ATF4 | More | | Citric-acid | hsa05031 | Amphetamine addiction | 4.47E-03 | 4 | Q13557, P63092, Q99941, P18848 | CAMK2D, GNAS, CREBL1, ATF4 | More | | Citric-acid | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 3.23E-04 | 2 | Q99437, P41240 | ATP6V0B, CSK | More | | Citric-acid | hsa05133 | Pertussis | 2.63E-02 | 2 | P10145, P0C0L4 | IL8, C4A | More | | Citric-acid | hsa05135 | Yersinia infection | 1.45E-02 | 5 | P06239, P01375, P42338, P49841, P01732 | LCK, TNF, PIK3CB, GSK3B, CD8A | More | | Citric-acid | hsa05140 | Leishmaniasis | 3.53E-02 | 6 | P13612, O75015, P13765, O60603, P01375, Q15080 | ITGA4, FCGR3B, HLA-DOB, TLR2, TNF, NCF4 | More | | Citric-acid | hsa05142 | Chagas disease | 3.97E-02 | 4 | P01375, P42338, P07766, P20963 | TNF, PIK3CB, CD3E, CD247 | More | | Citric-acid | hsa05143 | African trypanosomiasis | 1.35E-02 | 2 | P69905, P68871 | HBA2, HBB | More | | Citric-acid | hsa05144 | Malaria | 5.11E-07 | 8 | P60033, P69905, P68871, O60603, P01375, P05107, P35443, P26718 | CD81, HBA2, HBB, TLR2, TNF, ITGB2, THBS4, KLRK1 | More | | Citric-acid | hsa05146 | Amoebiasis | 1.48E-09 | 10 | P09341, P14778, P27930, P01375, O60603, P42338, P05089, P22694, P12814, P08311 | CXCL1, IL1R1, IL1R2, TNF, TLR2, PIK3CB, ARG1, PRKACB, ACTN1, CTSG | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P12724 | RNASE3 | Eosinophil cationic protein | P09341 | CXCL1 | Growth-regulated alpha protein | 0.752 | P42681 | TXK | Tyrosine-protein kinase TXK | P09341 | CXCL1 | Growth-regulated alpha protein | -0.881 | P10153 | RNASE2 | Non-secretory ribonuclease | P09341 | CXCL1 | Growth-regulated alpha protein | 0.701 | P06239 | LCK | Tyrosine-protein kinase Lck | P09341 | CXCL1 | Growth-regulated alpha protein | -0.805 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P09341 | CXCL1 | Growth-regulated alpha protein | -0.802 | P06239 | LCK | Tyrosine-protein kinase Lck | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.782 | P12724 | RNASE3 | Eosinophil cationic protein | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.714 | P10153 | RNASE2 | Non-secretory ribonuclease | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.749 | P06239 | LCK | Tyrosine-protein kinase Lck | P27930 | IL1R2 | Interleukin-1 receptor type 2 | -0.779 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P27930 | IL1R2 | Interleukin-1 receptor type 2 | -0.727 | P12724 | RNASE3 | Eosinophil cationic protein | P01375 | TNF | Tumor necrosis factor | 0.774 | P10153 | RNASE2 | Non-secretory ribonuclease | P01375 | TNF | Tumor necrosis factor | 0.735 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01375 | TNF | Tumor necrosis factor | -0.79 | P42681 | TXK | Tyrosine-protein kinase TXK | O60603 | TLR2 | Toll-like receptor 2 | -0.714 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | O60603 | TLR2 | Toll-like receptor 2 | -0.714 | P10153 | RNASE2 | Non-secretory ribonuclease | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.75 | P12724 | RNASE3 | Eosinophil cationic protein | P05089 | ARG1 | Arginase-1 | 0.877 | P42681 | TXK | Tyrosine-protein kinase TXK | P05089 | ARG1 | Arginase-1 | -0.739 | P10153 | RNASE2 | Non-secretory ribonuclease | P05089 | ARG1 | Arginase-1 | 0.856 | P06239 | LCK | Tyrosine-protein kinase Lck | P05089 | ARG1 | Arginase-1 | -0.803 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P05089 | ARG1 | Arginase-1 | -0.868 | P12724 | RNASE3 | Eosinophil cationic protein | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | -0.812 | P42681 | TXK | Tyrosine-protein kinase TXK | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | 0.878 | P10153 | RNASE2 | Non-secretory ribonuclease | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | -0.724 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | 0.873 | P10153 | RNASE2 | Non-secretory ribonuclease | P12814 | ACTN1 | Alpha-actinin-1 | 0.703 | P06239 | LCK | Tyrosine-protein kinase Lck | P12814 | ACTN1 | Alpha-actinin-1 | -0.867 | P12724 | RNASE3 | Eosinophil cationic protein | P08311 | CTSG | Cathepsin G | 0.938 | P42681 | TXK | Tyrosine-protein kinase TXK | P08311 | CTSG | Cathepsin G | -0.83 | P10153 | RNASE2 | Non-secretory ribonuclease | P08311 | CTSG | Cathepsin G | 0.844 | P06239 | LCK | Tyrosine-protein kinase Lck | P08311 | CTSG | Cathepsin G | -0.816 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P08311 | CTSG | Cathepsin G | -0.866 |
| Citric-acid | hsa05163 | Human cytomegalovirus infection | 4.01E-02 | 6 | P42338, P01375, P22694, P49841, Q13651, O00463 | PIK3CB, TNF, PRKACB, GSK3B, IL10RA, TRAF5 | More | | Citric-acid | hsa05169 | Epstein-Barr virus infection | 4.35E-05 | 15 | P13765, P01106, Q13547, O00463, P10415, P42338, P07948, Q13761, P24522, P01375, O60603, P29728, P07766, P09693, P20963 | HLA-DOB, MYC, HDAC1, TRAF5, BCL2, PIK3CB, LYN, RUNX3, GADD45A, TNF, TLR2, OAS2, CD3E, CD3G, CD247 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P42681 | TXK | Tyrosine-protein kinase TXK | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.89 | P10153 | RNASE2 | Non-secretory ribonuclease | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.724 | P06239 | LCK | Tyrosine-protein kinase Lck | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.777 | P06239 | LCK | Tyrosine-protein kinase Lck | P01106 | MYC | Myc proto-oncogene protein | 0.719 | P10153 | RNASE2 | Non-secretory ribonuclease | Q13547 | HDAC1 | Histone deacetylase 1 | -0.71 | P06239 | LCK | Tyrosine-protein kinase Lck | Q13547 | HDAC1 | Histone deacetylase 1 | 0.811 | P42681 | TXK | Tyrosine-protein kinase TXK | O00463 | TRAF5 | TNF receptor-associated factor 5 | 0.827 | P10153 | RNASE2 | Non-secretory ribonuclease | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.781 | P06239 | LCK | Tyrosine-protein kinase Lck | O00463 | TRAF5 | TNF receptor-associated factor 5 | 0.718 | P42681 | TXK | Tyrosine-protein kinase TXK | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.716 | P10153 | RNASE2 | Non-secretory ribonuclease | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.75 | P06239 | LCK | Tyrosine-protein kinase Lck | P07948 | LYN | Tyrosine-protein kinase Lyn | -0.701 | P10153 | RNASE2 | Non-secretory ribonuclease | Q13761 | RUNX3 | Runt-related transcription factor 3 | -0.755 | P06239 | LCK | Tyrosine-protein kinase Lck | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.85 | P42681 | TXK | Tyrosine-protein kinase TXK | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.79 | P06239 | LCK | Tyrosine-protein kinase Lck | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.724 | P10153 | RNASE2 | Non-secretory ribonuclease | P01375 | TNF | Tumor necrosis factor | 0.735 | P42681 | TXK | Tyrosine-protein kinase TXK | O60603 | TLR2 | Toll-like receptor 2 | -0.714 | P42681 | TXK | Tyrosine-protein kinase TXK | P29728 | OAS2 | 2'-5'-oligoadenylate synthase 2 | 0.831 | P10153 | RNASE2 | Non-secretory ribonuclease | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.795 | P06239 | LCK | Tyrosine-protein kinase Lck | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.928 | P42681 | TXK | Tyrosine-protein kinase TXK | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.838 | P06239 | LCK | Tyrosine-protein kinase Lck | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.752 | P42681 | TXK | Tyrosine-protein kinase TXK | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.811 | P10153 | RNASE2 | Non-secretory ribonuclease | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.893 | P06239 | LCK | Tyrosine-protein kinase Lck | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.927 |
| Citric-acid | hsa05202 | Transcriptional misregulation in cancer | 3.81E-04 | 15 | Q12778, Q13315, P41732, P14780, P27930, Q15744, Q16548, Q13077, O15550, P35226, P05164, P12838, P08246, Q9C0K0, P24522 | FOXO1, ATM, TSPAN7, MMP9, IL1R2, CEBPE, BCL2A1, TRAF1, UTX, BMI1, MPO, DEFA4, ELA2, BCL11B, GADD45A | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q12778 | FOXO1 | Forkhead box protein O1 | 0.795 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q13315 | ATM | Serine-protein kinase ATM | 0.752 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q13315 | ATM | Serine-protein kinase ATM | 0.723 | P42681 | TXK | Tyrosine-protein kinase TXK | P41732 | TSPAN7 | Tetraspanin-7 | -0.719 | P42681 | TXK | Tyrosine-protein kinase TXK | P14780 | MMP9 | Matrix metalloproteinase-9 | -0.762 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P14780 | MMP9 | Matrix metalloproteinase-9 | -0.855 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P14780 | MMP9 | Matrix metalloproteinase-9 | -0.746 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P27930 | IL1R2 | Interleukin-1 receptor type 2 | -0.727 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q15744 | CEBPE | CCAAT/enhancer-binding protein epsilon | -0.833 | P42681 | TXK | Tyrosine-protein kinase TXK | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.756 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.877 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.701 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q13077 | TRAF1 | TNF receptor-associated factor 1 | 0.83 | P42681 | TXK | Tyrosine-protein kinase TXK | O15550 | UTX | Lysine-specific demethylase 6A | -0.731 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | O15550 | UTX | Lysine-specific demethylase 6A | -0.778 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P35226 | BMI1 | Polycomb complex protein BMI-1 | 0.76 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P35226 | BMI1 | Polycomb complex protein BMI-1 | 0.76 | P42681 | TXK | Tyrosine-protein kinase TXK | P05164 | MPO | Myeloperoxidase | -0.829 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P05164 | MPO | Myeloperoxidase | -0.811 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P05164 | MPO | Myeloperoxidase | -0.866 | P42681 | TXK | Tyrosine-protein kinase TXK | P12838 | DEFA4 | Neutrophil defensin 4 | -0.707 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P12838 | DEFA4 | Neutrophil defensin 4 | -0.86 | P42681 | TXK | Tyrosine-protein kinase TXK | P08246 | ELA2 | Neutrophil elastase | -0.756 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P08246 | ELA2 | Neutrophil elastase | -0.782 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P08246 | ELA2 | Neutrophil elastase | -0.76 | P42681 | TXK | Tyrosine-protein kinase TXK | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | 0.874 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | 0.9 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | 0.879 | P42681 | TXK | Tyrosine-protein kinase TXK | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.79 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.75 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.734 |
| Citric-acid | hsa05203 | Viral carcinogenesis | 9.40E-04 | 8 | Q12933, Q99941, P18848, P42229, P27348, Q15283, P61586, P61978 | TRAF2, CREBL1, ATF4, STAT5A, YWHAQ, RASA2, RHOA, HNRPK | More | | Citric-acid | hsa05204 | Chemical carcinogenesis | 5.46E-03 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | Citric-acid | hsa05205 | Proteoglycans in cancer | 4.43E-02 | 3 | P63261, O60603, Q06124 | ACTG1, TLR2, PTPN11 | More | | Citric-acid | hsa05206 | MicroRNAs in cancer | 1.54E-02 | 6 | P21860, P61978, P46531, P63279, P22105, P61586 | ERBB3, HNRPK, NOTCH1, UBE2I, TNXB, RHOA | More | | Citric-acid | hsa05211 | Renal cell carcinoma | 1.97E-02 | 2 | Q06124, Q99814 | PTPN11, EPAS1 | More | | Citric-acid | hsa05225 | Hepatocellular carcinoma | 2.57E-02 | 4 | P04628, P63261, Q6STE5, Q969G3 | WNT1, ACTG1, SMARCD3, SMARCE1 | More | | Citric-acid | hsa05231 | Choline metabolism in cancer | 2.22E-02 | 2 | Q9GZP0, P17252 | PDGFD, PRKCA | More | | Citric-acid | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 3.65E-07 | 10 | P42338, O95267, P07766, P20963, P09693, P06239, O60603, P10747, Q04759, P01730 | PIK3CB, RASGRP1, CD3E, CD247, CD3G, LCK, TLR2, CD28, PRKCQ, CD4 | More | | Citric-acid | hsa05310 | Asthma | 1.20E-06 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Citric-acid | hsa05321 | Inflammatory bowel disease | 1.69E-15 | 7 | O60603, P01375, P13765, Q14765, Q9UL17, P23771, Q9HBE5 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3, IL21R | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P42681 | TXK | Tyrosine-protein kinase TXK | O60603 | TLR2 | Toll-like receptor 2 | -0.714 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | O60603 | TLR2 | Toll-like receptor 2 | -0.714 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | O60603 | TLR2 | Toll-like receptor 2 | -0.717 | P12724 | RNASE3 | Eosinophil cationic protein | P01375 | TNF | Tumor necrosis factor | 0.774 | P10153 | RNASE2 | Non-secretory ribonuclease | P01375 | TNF | Tumor necrosis factor | 0.735 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01375 | TNF | Tumor necrosis factor | -0.79 | P12724 | RNASE3 | Eosinophil cationic protein | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.856 | P42681 | TXK | Tyrosine-protein kinase TXK | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.89 | P10153 | RNASE2 | Non-secretory ribonuclease | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.724 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.85 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.795 | P12724 | RNASE3 | Eosinophil cationic protein | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.835 | P42681 | TXK | Tyrosine-protein kinase TXK | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.771 | P10153 | RNASE2 | Non-secretory ribonuclease | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.772 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.904 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.742 | P12724 | RNASE3 | Eosinophil cationic protein | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.805 | P42681 | TXK | Tyrosine-protein kinase TXK | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.849 | P10153 | RNASE2 | Non-secretory ribonuclease | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.852 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.884 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.735 | P12724 | RNASE3 | Eosinophil cationic protein | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.71 | P42681 | TXK | Tyrosine-protein kinase TXK | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.856 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.784 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.85 | P12724 | RNASE3 | Eosinophil cationic protein | Q9HBE5 | IL21R | Interleukin-21 receptor | -0.839 | P10153 | RNASE2 | Non-secretory ribonuclease | Q9HBE5 | IL21R | Interleukin-21 receptor | -0.777 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q9HBE5 | IL21R | Interleukin-21 receptor | 0.713 |
| Citric-acid | hsa05323 | Rheumatoid arthritis | 8.71E-04 | 4 | P13765, P10747, P09341, O60603 | HLA-DOB, CD28, CXCL1, TLR2 | More | | Citric-acid | hsa05332 | Graft-versus-host disease | 2.19E-10 | 5 | P13765, P10747, P01375, P26715, Q13241 | HLA-DOB, CD28, TNF, KLRC1, KLRD1 | More | | Citric-acid | hsa05340 | Primary immunodeficiency | 2.19E-02 | 4 | P01730, P01732, P07766, P06239 | CD4, CD8A, CD3E, LCK | More | | Citric-acid | hsa05410 | Hypertrophic cardiomyopathy | 1.35E-02 | 2 | P26012, P09493 | ITGB8, TPM1 | More | | Citric-acid | hsa05415 | Diabetic cardiomyopathy | 1.92E-02 | 6 | P05141, P12236, O15239, P05496, Q13557, P26678 | SLC25A5, SLC25A6, NDUFA1, ATP5G1, CAMK2D, PLN | More | | Citric-acid | hsa05416 | Viral myocarditis | 3.89E-02 | 2 | P10747, P63261 | CD28, ACTG1 | More | | Citric-acid | hsa05418 | Fluid shear stress and atherosclerosis | 3.77E-02 | 5 | P42338, Q14145, P10599, P01375, P27930 | PIK3CB, KEAP1, TXN, TNF, IL1R2 | More | | |